Extracellular signal-regulated kinase signaling pathway regulates breast cancer cell migration by maintaining slug expression

Haoming Chen, Genfeng Zhu, Yong Li, Ravi N. Padia, Zheng Dong, Zhixing K. Pan, Kebin Liu, Shuang Huang

Research output: Contribution to journalArticle

123 Citations (Scopus)

Abstract

Cell migration is a critical step in cancer cell invasion. Recent studies have implicated the importance of the extracellular signal-regulated kinase (ERK) signaling pathway in cancer cell migration. However, the mechanism associated with ERK-regulated cell migration is poorly understood. Using a panel of breast cancer cell lines, we detected an excellent correlation between ERK activity and cell migration. Interestingly, we noticed that a 48-hour treatment with U0126 [specific mitogen-activated protein/ERK kinase (MEK)-1/2 inhibitor] was needed to significantly inhibit breast cancer cell migration, whereas this inhibitor blocked ERK activity within 1 hour. This observation suggests that ERK-dependent gene expression, rather than direct ERK signaling, is essential for cell migration. With further study, we found that ERK activity promoted the expression of the activator protein-1 (AP1) components Fra-1 and c-Jun, both of which were necessary for cell migration. Combination of U0126 treatment and Fra-1/c-Jun knockdown did not yield further reduction in cell migration than either alone, indicating that ERKs and Fra-1/c-Jun act by the same mechanism to facilitate cell migration. In an attempt to investigate the role of Fra-1/c-Jun in cell migration, we found that the ERK-Fra-1/c-Jun axis regulated slug expression in an AP1-dependent manner. Moreover, the occurrence of U0126-induced migratory inhibition coincided with slug reduction, and silencing slug expression abrogated breast cancer cell migration. These results suggest an association between ERK-regulated cell migration and slug expression. Indeed, cell migration was not significantly inhibited by U0126 treatment or Fra-1/c-Jun silencing in cells expressing slug transgene. Our study suggests that the ERK pathway regulates breast cancer cell migration by maintaining slug expression.

Original languageEnglish (US)
Pages (from-to)9228-9235
Number of pages8
JournalCancer Research
Volume69
Issue number24
DOIs
StatePublished - Dec 15 2009

Fingerprint

Gastropoda
Extracellular Signal-Regulated MAP Kinases
Cell Movement
Breast Neoplasms
Transcription Factor AP-1
Mitogen-Activated Protein Kinase 3
Transgenes
Mitogens

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Extracellular signal-regulated kinase signaling pathway regulates breast cancer cell migration by maintaining slug expression. / Chen, Haoming; Zhu, Genfeng; Li, Yong; Padia, Ravi N.; Dong, Zheng; Pan, Zhixing K.; Liu, Kebin; Huang, Shuang.

In: Cancer Research, Vol. 69, No. 24, 15.12.2009, p. 9228-9235.

Research output: Contribution to journalArticle

Chen, Haoming ; Zhu, Genfeng ; Li, Yong ; Padia, Ravi N. ; Dong, Zheng ; Pan, Zhixing K. ; Liu, Kebin ; Huang, Shuang. / Extracellular signal-regulated kinase signaling pathway regulates breast cancer cell migration by maintaining slug expression. In: Cancer Research. 2009 ; Vol. 69, No. 24. pp. 9228-9235.
@article{a850452b5d044ff4bf779ce85a79714c,
title = "Extracellular signal-regulated kinase signaling pathway regulates breast cancer cell migration by maintaining slug expression",
abstract = "Cell migration is a critical step in cancer cell invasion. Recent studies have implicated the importance of the extracellular signal-regulated kinase (ERK) signaling pathway in cancer cell migration. However, the mechanism associated with ERK-regulated cell migration is poorly understood. Using a panel of breast cancer cell lines, we detected an excellent correlation between ERK activity and cell migration. Interestingly, we noticed that a 48-hour treatment with U0126 [specific mitogen-activated protein/ERK kinase (MEK)-1/2 inhibitor] was needed to significantly inhibit breast cancer cell migration, whereas this inhibitor blocked ERK activity within 1 hour. This observation suggests that ERK-dependent gene expression, rather than direct ERK signaling, is essential for cell migration. With further study, we found that ERK activity promoted the expression of the activator protein-1 (AP1) components Fra-1 and c-Jun, both of which were necessary for cell migration. Combination of U0126 treatment and Fra-1/c-Jun knockdown did not yield further reduction in cell migration than either alone, indicating that ERKs and Fra-1/c-Jun act by the same mechanism to facilitate cell migration. In an attempt to investigate the role of Fra-1/c-Jun in cell migration, we found that the ERK-Fra-1/c-Jun axis regulated slug expression in an AP1-dependent manner. Moreover, the occurrence of U0126-induced migratory inhibition coincided with slug reduction, and silencing slug expression abrogated breast cancer cell migration. These results suggest an association between ERK-regulated cell migration and slug expression. Indeed, cell migration was not significantly inhibited by U0126 treatment or Fra-1/c-Jun silencing in cells expressing slug transgene. Our study suggests that the ERK pathway regulates breast cancer cell migration by maintaining slug expression.",
author = "Haoming Chen and Genfeng Zhu and Yong Li and Padia, {Ravi N.} and Zheng Dong and Pan, {Zhixing K.} and Kebin Liu and Shuang Huang",
year = "2009",
month = "12",
day = "15",
doi = "10.1158/0008-5472.CAN-09-1950",
language = "English (US)",
volume = "69",
pages = "9228--9235",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "24",

}

TY - JOUR

T1 - Extracellular signal-regulated kinase signaling pathway regulates breast cancer cell migration by maintaining slug expression

AU - Chen, Haoming

AU - Zhu, Genfeng

AU - Li, Yong

AU - Padia, Ravi N.

AU - Dong, Zheng

AU - Pan, Zhixing K.

AU - Liu, Kebin

AU - Huang, Shuang

PY - 2009/12/15

Y1 - 2009/12/15

N2 - Cell migration is a critical step in cancer cell invasion. Recent studies have implicated the importance of the extracellular signal-regulated kinase (ERK) signaling pathway in cancer cell migration. However, the mechanism associated with ERK-regulated cell migration is poorly understood. Using a panel of breast cancer cell lines, we detected an excellent correlation between ERK activity and cell migration. Interestingly, we noticed that a 48-hour treatment with U0126 [specific mitogen-activated protein/ERK kinase (MEK)-1/2 inhibitor] was needed to significantly inhibit breast cancer cell migration, whereas this inhibitor blocked ERK activity within 1 hour. This observation suggests that ERK-dependent gene expression, rather than direct ERK signaling, is essential for cell migration. With further study, we found that ERK activity promoted the expression of the activator protein-1 (AP1) components Fra-1 and c-Jun, both of which were necessary for cell migration. Combination of U0126 treatment and Fra-1/c-Jun knockdown did not yield further reduction in cell migration than either alone, indicating that ERKs and Fra-1/c-Jun act by the same mechanism to facilitate cell migration. In an attempt to investigate the role of Fra-1/c-Jun in cell migration, we found that the ERK-Fra-1/c-Jun axis regulated slug expression in an AP1-dependent manner. Moreover, the occurrence of U0126-induced migratory inhibition coincided with slug reduction, and silencing slug expression abrogated breast cancer cell migration. These results suggest an association between ERK-regulated cell migration and slug expression. Indeed, cell migration was not significantly inhibited by U0126 treatment or Fra-1/c-Jun silencing in cells expressing slug transgene. Our study suggests that the ERK pathway regulates breast cancer cell migration by maintaining slug expression.

AB - Cell migration is a critical step in cancer cell invasion. Recent studies have implicated the importance of the extracellular signal-regulated kinase (ERK) signaling pathway in cancer cell migration. However, the mechanism associated with ERK-regulated cell migration is poorly understood. Using a panel of breast cancer cell lines, we detected an excellent correlation between ERK activity and cell migration. Interestingly, we noticed that a 48-hour treatment with U0126 [specific mitogen-activated protein/ERK kinase (MEK)-1/2 inhibitor] was needed to significantly inhibit breast cancer cell migration, whereas this inhibitor blocked ERK activity within 1 hour. This observation suggests that ERK-dependent gene expression, rather than direct ERK signaling, is essential for cell migration. With further study, we found that ERK activity promoted the expression of the activator protein-1 (AP1) components Fra-1 and c-Jun, both of which were necessary for cell migration. Combination of U0126 treatment and Fra-1/c-Jun knockdown did not yield further reduction in cell migration than either alone, indicating that ERKs and Fra-1/c-Jun act by the same mechanism to facilitate cell migration. In an attempt to investigate the role of Fra-1/c-Jun in cell migration, we found that the ERK-Fra-1/c-Jun axis regulated slug expression in an AP1-dependent manner. Moreover, the occurrence of U0126-induced migratory inhibition coincided with slug reduction, and silencing slug expression abrogated breast cancer cell migration. These results suggest an association between ERK-regulated cell migration and slug expression. Indeed, cell migration was not significantly inhibited by U0126 treatment or Fra-1/c-Jun silencing in cells expressing slug transgene. Our study suggests that the ERK pathway regulates breast cancer cell migration by maintaining slug expression.

UR - http://www.scopus.com/inward/record.url?scp=73649124286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73649124286&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-09-1950

DO - 10.1158/0008-5472.CAN-09-1950

M3 - Article

C2 - 19920183

AN - SCOPUS:73649124286

VL - 69

SP - 9228

EP - 9235

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 24

ER -